The British HIV Association (BHIVA) has recommended that everyone living with HIV aged 40 and over should take a statin to reduce their risk of heart disease, even if they do not have raised cholesterol or a high risk of heart disease.
The new guidance is the first in the world to respond to the results of the REPRIVE study, presented at the International AIDS Society Conference on HIV Science in July. The study showed that taking pitavastatin daily reduced the risk of a major cardiovascular event such as heart attack, stroke or a clinical intervention to treat a serious heart disorder by 35% in people with HIV. Crucially, the study only recruited people with a low-to-moderate risk of serious heart disease within ten years.
Read the full story at Aidsmap.
Source : Aidsmap
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.